News

HDA Media And Political Bulletin – 27 September 2016

Harris confirms bid to house European Medicines Agency

26 September 2016, Irish Independent, Gavin McLoughlin

 

The Irish Minister for Health, Simon Harris, has confirmed that Ireland will be launching a formal bid to become the new host country of the European Medicines Agency (EMA). Speaking at a pharmaceuticals industry conference, Mr Harris announced that his department had already begun laying the groundwork for a formal bid. He believes that it is important for the EMA’s work to face as little disruption as possible when it is relocated from London in the next few years. Officials representing Strasbourg, Lyon, Barcelona, Madrid, Stockholm, Warsaw, Vienna and Milan have already expressed an interest in housing the EMA headquarters. However, the Chief Executive of the Irish Pharmaceutical Healthcare Association, Oliver O’Connor, believes that Ireland has “a strong case” for housing the EMA in the future.

Parliamentary Coverage

 

There is no parliamentary coverage today.

 

Full Coverage

Harris confirms bid to house European Medicines Agency

26 September 2016, Irish Independent, Gavin McLoughlin

 

Health Minister Simon Harris has confirmed that Ireland will launch a formal bid to house the European Medicines Agency (EMA).

He said attracting the EMA was “one of the more interesting opportunities” afforded by Brexit.

“Given the importance of the EMA’s work…it’s important that any disruption to the agency’s work should be kept to a minimum when it relocates from London, probably within the next couple of years,” Mr Harris said at a pharmaceuticals industry conference in Dublin last week.

“My department…has already begun to lay the groundwork for preparing a formal bid, and I know that your industry will support our efforts to bring this prestigious agency to Dublin,” he added. The EMA is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU.

It employs around 900 people, including temporary staff, and is highly sought-after by other EU countries, along with the European Banking Authority (EBA), which is also set to leave London after the Brexit vote. Officials representing Strasbourg, Lyon, Barcelona, and Milan have already expressed interest in the EMA.

Reuters has previously reported that Madrid, Stockholm, Warsaw and Vienna are also in the race to grab one or other organisation in the knowledge that banks and drugmakers will want to maintain close ties with key regulators.

Irish Pharmaceutical Healthcare Association chief executive Oliver O’Connor told the Irish Independent that Ireland had “a strong case” for housing the EMA.

“I think it would be a very good addition to the capability that Ireland has already demonstrated on a global scale for manufacturing, development, and high regulatory standards,” he added.

HDA Media And Political Bulletin – 27 September 2016

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?